Promoter Sequence of Shiga Toxin 2 (Stx2) Is Recognized <italic toggle="yes">In Vivo</italic>, Leading to Production of Biologically Active Stx2

ABSTRACT Shiga toxins (Stx) are the main agent responsible for the development of hemolytic-uremic syndrome (HUS), the most severe and life-threatening systemic complication of infection with enterohemorrhagic Escherichia coli (EHEC) strains. We previously described Stx2 expression by eukaryotic cel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Leticia V. Bentancor, Maria P. Mejías, Alípio Pinto, Marcos F. Bilen, Roberto Meiss, Maria C. Rodriguez-Galán, Natalia Baez, Luciano P. Pedrotti, Jorge Goldstein, Pablo D. Ghiringhelli, Marina S. Palermo
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2013
Materias:
Acceso en línea:https://doaj.org/article/5e0d13c891a543099a0c1b08237d2f36
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5e0d13c891a543099a0c1b08237d2f36
record_format dspace
spelling oai:doaj.org-article:5e0d13c891a543099a0c1b08237d2f362021-11-15T15:42:47ZPromoter Sequence of Shiga Toxin 2 (Stx2) Is Recognized <italic toggle="yes">In Vivo</italic>, Leading to Production of Biologically Active Stx210.1128/mBio.00501-132150-7511https://doaj.org/article/5e0d13c891a543099a0c1b08237d2f362013-11-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00501-13https://doaj.org/toc/2150-7511ABSTRACT Shiga toxins (Stx) are the main agent responsible for the development of hemolytic-uremic syndrome (HUS), the most severe and life-threatening systemic complication of infection with enterohemorrhagic Escherichia coli (EHEC) strains. We previously described Stx2 expression by eukaryotic cells after they were transfected in vitro with the stx2 gene cloned into a prokaryotic plasmid (pStx2). The aim of this study was to evaluate whether mammalian cells were also able to express Stx2 in vivo after pStx2 injection. Mice were inoculated by hydrodynamics-based transfection (HBT) with pStx2. We studied the survival, percentage of polymorphonuclear leukocytes in plasma, plasma urea levels, and histology of the kidneys and the brains of mice. Mice displayed a lethal dose-related response to pStx2. Stx2 mRNA was recovered from the liver, and Stx2 cytotoxic activity was observed in plasma of mice injected with pStx2. Stx2 was detected by immunofluorescence in the brains of mice inoculated with pStx2, and markers of central nervous system (CNS) damage were observed, including increased expression of glial fibrillary acidic protein (GFAP) and fragmentation of NeuN in neurons. Moreover, anti-Stx2B-immunized mice were protected against pStx2 inoculation. Our results show that Stx2 is expressed in vivo from the wild stx2 gene, reproducing pathogenic damage induced by purified Stx2 or secondary to EHEC infection. IMPORTANCE Enterohemorrhagic Shiga toxin (Stx)-producing Escherichia coli (EHEC) infections are a serious public health problem, and Stx is the main pathogenic agent associated with typical hemolytic-uremic syndrome (HUS). In contrast to the detailed information describing the molecular basis for EHEC adherence to epithelial cells, very little is known about how Stx is released from bacteria in the gut, reaching its target tissues, mainly the kidney and central nervous system (CNS). In order to develop an efficient treatment for EHEC infections, it is necessary to understand the mechanisms involved in Stx expression. In this regard, the present study demonstrates that mammals can synthesize biologically active Stx using the natural promoter associated with the Stx-converting bacteriophage genome. These results could impact the comprehension of EHEC HUS, since local eukaryotic cells transduced and/or infected by bacteriophage encoding Stx2 could be an alternative source of Stx production.Leticia V. BentancorMaria P. MejíasAlípio PintoMarcos F. BilenRoberto MeissMaria C. Rodriguez-GalánNatalia BaezLuciano P. PedrottiJorge GoldsteinPablo D. GhiringhelliMarina S. PalermoAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 4, Iss 5 (2013)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Leticia V. Bentancor
Maria P. Mejías
Alípio Pinto
Marcos F. Bilen
Roberto Meiss
Maria C. Rodriguez-Galán
Natalia Baez
Luciano P. Pedrotti
Jorge Goldstein
Pablo D. Ghiringhelli
Marina S. Palermo
Promoter Sequence of Shiga Toxin 2 (Stx2) Is Recognized <italic toggle="yes">In Vivo</italic>, Leading to Production of Biologically Active Stx2
description ABSTRACT Shiga toxins (Stx) are the main agent responsible for the development of hemolytic-uremic syndrome (HUS), the most severe and life-threatening systemic complication of infection with enterohemorrhagic Escherichia coli (EHEC) strains. We previously described Stx2 expression by eukaryotic cells after they were transfected in vitro with the stx2 gene cloned into a prokaryotic plasmid (pStx2). The aim of this study was to evaluate whether mammalian cells were also able to express Stx2 in vivo after pStx2 injection. Mice were inoculated by hydrodynamics-based transfection (HBT) with pStx2. We studied the survival, percentage of polymorphonuclear leukocytes in plasma, plasma urea levels, and histology of the kidneys and the brains of mice. Mice displayed a lethal dose-related response to pStx2. Stx2 mRNA was recovered from the liver, and Stx2 cytotoxic activity was observed in plasma of mice injected with pStx2. Stx2 was detected by immunofluorescence in the brains of mice inoculated with pStx2, and markers of central nervous system (CNS) damage were observed, including increased expression of glial fibrillary acidic protein (GFAP) and fragmentation of NeuN in neurons. Moreover, anti-Stx2B-immunized mice were protected against pStx2 inoculation. Our results show that Stx2 is expressed in vivo from the wild stx2 gene, reproducing pathogenic damage induced by purified Stx2 or secondary to EHEC infection. IMPORTANCE Enterohemorrhagic Shiga toxin (Stx)-producing Escherichia coli (EHEC) infections are a serious public health problem, and Stx is the main pathogenic agent associated with typical hemolytic-uremic syndrome (HUS). In contrast to the detailed information describing the molecular basis for EHEC adherence to epithelial cells, very little is known about how Stx is released from bacteria in the gut, reaching its target tissues, mainly the kidney and central nervous system (CNS). In order to develop an efficient treatment for EHEC infections, it is necessary to understand the mechanisms involved in Stx expression. In this regard, the present study demonstrates that mammals can synthesize biologically active Stx using the natural promoter associated with the Stx-converting bacteriophage genome. These results could impact the comprehension of EHEC HUS, since local eukaryotic cells transduced and/or infected by bacteriophage encoding Stx2 could be an alternative source of Stx production.
format article
author Leticia V. Bentancor
Maria P. Mejías
Alípio Pinto
Marcos F. Bilen
Roberto Meiss
Maria C. Rodriguez-Galán
Natalia Baez
Luciano P. Pedrotti
Jorge Goldstein
Pablo D. Ghiringhelli
Marina S. Palermo
author_facet Leticia V. Bentancor
Maria P. Mejías
Alípio Pinto
Marcos F. Bilen
Roberto Meiss
Maria C. Rodriguez-Galán
Natalia Baez
Luciano P. Pedrotti
Jorge Goldstein
Pablo D. Ghiringhelli
Marina S. Palermo
author_sort Leticia V. Bentancor
title Promoter Sequence of Shiga Toxin 2 (Stx2) Is Recognized <italic toggle="yes">In Vivo</italic>, Leading to Production of Biologically Active Stx2
title_short Promoter Sequence of Shiga Toxin 2 (Stx2) Is Recognized <italic toggle="yes">In Vivo</italic>, Leading to Production of Biologically Active Stx2
title_full Promoter Sequence of Shiga Toxin 2 (Stx2) Is Recognized <italic toggle="yes">In Vivo</italic>, Leading to Production of Biologically Active Stx2
title_fullStr Promoter Sequence of Shiga Toxin 2 (Stx2) Is Recognized <italic toggle="yes">In Vivo</italic>, Leading to Production of Biologically Active Stx2
title_full_unstemmed Promoter Sequence of Shiga Toxin 2 (Stx2) Is Recognized <italic toggle="yes">In Vivo</italic>, Leading to Production of Biologically Active Stx2
title_sort promoter sequence of shiga toxin 2 (stx2) is recognized <italic toggle="yes">in vivo</italic>, leading to production of biologically active stx2
publisher American Society for Microbiology
publishDate 2013
url https://doaj.org/article/5e0d13c891a543099a0c1b08237d2f36
work_keys_str_mv AT leticiavbentancor promotersequenceofshigatoxin2stx2isrecognizeditalictoggleyesinvivoitalicleadingtoproductionofbiologicallyactivestx2
AT mariapmejias promotersequenceofshigatoxin2stx2isrecognizeditalictoggleyesinvivoitalicleadingtoproductionofbiologicallyactivestx2
AT alipiopinto promotersequenceofshigatoxin2stx2isrecognizeditalictoggleyesinvivoitalicleadingtoproductionofbiologicallyactivestx2
AT marcosfbilen promotersequenceofshigatoxin2stx2isrecognizeditalictoggleyesinvivoitalicleadingtoproductionofbiologicallyactivestx2
AT robertomeiss promotersequenceofshigatoxin2stx2isrecognizeditalictoggleyesinvivoitalicleadingtoproductionofbiologicallyactivestx2
AT mariacrodriguezgalan promotersequenceofshigatoxin2stx2isrecognizeditalictoggleyesinvivoitalicleadingtoproductionofbiologicallyactivestx2
AT nataliabaez promotersequenceofshigatoxin2stx2isrecognizeditalictoggleyesinvivoitalicleadingtoproductionofbiologicallyactivestx2
AT lucianoppedrotti promotersequenceofshigatoxin2stx2isrecognizeditalictoggleyesinvivoitalicleadingtoproductionofbiologicallyactivestx2
AT jorgegoldstein promotersequenceofshigatoxin2stx2isrecognizeditalictoggleyesinvivoitalicleadingtoproductionofbiologicallyactivestx2
AT pablodghiringhelli promotersequenceofshigatoxin2stx2isrecognizeditalictoggleyesinvivoitalicleadingtoproductionofbiologicallyactivestx2
AT marinaspalermo promotersequenceofshigatoxin2stx2isrecognizeditalictoggleyesinvivoitalicleadingtoproductionofbiologicallyactivestx2
_version_ 1718427586605875200